AHA Scientific Sessions 2025 Abstract·3 NovRN0361, an siRNA Directed Against ApoC3 Demonstrates Potent and Durable Reduction of ApoC3 and Triglyceride Over 6 Months in the ClinicTrial in peopleInterventionsPaper